INSM
Insmed Inc
Price:  
68.12 
USD
Volume:  
1,788,384.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

INSM EV/EBITDA

-196.6%
Upside

As of 2025-05-18, the EV/EBITDA ratio of Insmed Inc (INSM) is -15.59. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INSM's latest enterprise value is 13,113.72 mil USD. INSM's TTM EBITDA according to its financial statements is -841.27 mil USD. Dividing these 2 quantities gives us the above INSM EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 11.0x - 13.7x 13.4x
Forward P/E multiples 12.4x - 14.4x 13.3x
Fair Price (61.29) - (67.21) (65.77)
Upside -190.0% - -198.7% -196.6%
68.12 USD
Stock Price
(65.77) USD
Fair Price

INSM EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-05-16 -15.59
2025-05-15 -15.39
2025-05-14 -15.05
2025-05-13 -15.07
2025-05-12 -15.51
2025-05-09 -14.93
2025-05-08 -15.05
2025-05-07 -15.62
2025-05-06 -15.53
2025-05-05 -16.55
2025-05-02 -16.49
2025-05-01 -16.56
2025-04-30 -16.43
2025-04-29 -16.30
2025-04-28 -15.96
2025-04-25 -15.93
2025-04-24 -15.77
2025-04-23 -16.17
2025-04-22 -16.26
2025-04-21 -15.89
2025-04-17 -16.57
2025-04-16 -16.04
2025-04-15 -16.23
2025-04-14 -16.22
2025-04-11 -15.69
2025-04-10 -14.87
2025-04-09 -15.46
2025-04-08 -14.91
2025-04-07 -15.58
2025-04-04 -15.82
2025-04-03 -16.71
2025-04-02 -16.74
2025-04-01 -16.43
2025-03-31 -17.35
2025-03-28 -17.72
2025-03-27 -17.66
2025-03-26 -17.41
2025-03-25 -17.84
2025-03-24 -18.02
2025-03-21 -18.14
2025-03-20 -17.89
2025-03-19 -17.93
2025-03-18 -17.51
2025-03-17 -17.67
2025-03-14 -17.41
2025-03-13 -17.09
2025-03-12 -16.87
2025-03-11 -16.79
2025-03-10 -16.66
2025-03-07 -17.05